Smoking cessation I read with interest the leader by Patrick White. 1 I share his enthusiasm for smoking cessation and pulmonary rehabilitation. I do not, however, share his enthusiasm for inhaler therapy beyond short-term betaagonists. The evidence for long-term reductions in exacerbations and admissions is there but it is hardly striking. I do not think that we should extrapolate reductions in mortality until that evidence is there. The fact that it is not already, suggests that any reductions, sadly, won't be too great.
been a vast amount of evidence 2, 3 published already about the safety of MMR in children with egg allergy. In spite of various recommendations and guidelines, children are still being referred for MMR to be administered in a hospital setting.
The guidance in the UK surrounding MMR and egg allergy has changed over the years. The recommendations for MMR vaccine in egg allergic children were published in 2000. 1 It stated that children with mild egg allergy can be safely vaccinated in primary care and recommended that children with previous significant allergic reactions should be vaccinated in hospital. Most of our practice is still based on these recommendations.
The latest British Society of Allergy and Clinical Immunology (BSACI) guidance recommends that all children with egg allergy should be immunised in primary care. 'Children who have had documented anaphylaxis to the vaccine itself should be assessed by an allergist'. 4 Our approach has always been to write back to GPs or to speak to them directly about the safety of MMR in egg allergy. We, however, do not know if any of these children did ever go on to have the vaccine in primary care.
We agree with the recommendation by Ainsworth et al 5 of attaching a copy of BSACI guidelines when we write back to our GPs. Although the guidelines have been published, there is still a possibility that many of our colleagues in primary care are not aware of them. We believe that inclusion of these recommendations in all the immunisation leaflets and related websites would lead to increased awareness and reduce the confusion surrounding this controversy. We hope that the green book would include the same advice in its next edition. My concerns are that, once labelled the path of prescribing moves almost automatically to short-acting betaagonists, long-acting beta-agonists, and inhaled steroids in all patients, even in those with mild disease and even in those with no objective or subjective hard evidence of improvement. How can we make treatment more objectively useful?
I do not want to be a therapeutic nihilist but equally this disease needs cost effective, evidence-based treatments that are re-assessed and stopped if they don't work. A huge sum is being spent promoting the benefits of multiple treatments, but rarely do these promotions emphasise, for instance, the increased pneumonias in people with chronic obstructive pulmonary disease who are being treated with inhaled steroids. We do receive a number of referrals every year (10-15) from GPs for MMR to be administered in a hospital setting. The live measles and mumps vaccine is grown on cultured chick embryo fibroblasts and there is a concern that there could be some amount of egg protein in the vaccine. The controversy surrounding MMR and egg allergy has been long standing even though the hen's egg protein in the vaccine is highly processed and the concentrations are very low to trigger any allergic reaction. 
John Sharvill,

GP, Balmoral
Physical activity promotion
Davies and Garbutt wrote an important and commendable editorial on exercise prescription; 1 however, there are some fundamental issues raised requiring clarification and further consideration.
First, when measured objectively, a staggering 95% of the adult population (UK and US) do not meet the minimum recommended levels of physical activity to confer basic health benefits. 2, 3 Second, most chronic diseases reflect the pandemic syndrome of physical inactivity. This predisposes the inactive majority to osteoporosis, muscle atrophy, low back pain, coronary artery disease, peripheral artery disease, stroke, hypertension, type 2 diabetes, obesity, dyslipidemia, metabolic syndrome, some cancers (for example, breast cancer), implementing good medical practice and promoting physical activity to their patients at every appropriate opportunity.
Physical activity is a natural pill and both a cure and prevention for many ills. Given the way that modern medicine is practised and influenced, perhaps if we thought of physical inactivity as a disease in its own right and physical activity as a medication in the same way as prescribed drugs we may begin to make some progress to the benefit of nearly all our patients, the finances of the NHS, and society. 
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